Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Racotumomab, which improves lung cancer survival rate, soon to be available in Argentina

June 10, 2013

DMC recommends continuation of phase II ICT-107 trial

June 10, 2013

Millennium presents preclinical results for novel antibody-drug conjugate MLN-0264

June 10, 2013

First-in-human data for vantictumab, an antibody targeting the Wnt pathway

June 6, 2013

Lambrolizumab shows significant activity and durable response in patients with melanoma

June 5, 2013

MEDI-551 shows efficacy in patients with CLL

June 4, 2013

GC-1008 is well tolerated but shows no clinical benefit in patients with glioma

June 3, 2013

Phase II trial to evaluate Immunovaccine's DPX-Survivac in glioblastoma

May 31, 2013

Early clinical results reported for a novel cell-based gene therapy for melanoma

May 30, 2013

Phase I/IIa study of dendritic cell-based vaccine for AML meets endpoints

May 29, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...